Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SIEGMAN-IGRA, Y.
Right arrow Articles by GILAT, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SIEGMAN-IGRA, Y.
Right arrow Articles by GILAT, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1976 British Society for Rheumatology


other

COLITIS AND DEATH FOLLOWING GOLD THERAPY

Y. SIEGMAN-IGRA, M. YARON, M. SILETZKI, E. SCHUJMAN and T. GILAT

Departments of Internal Medicine, Physical Medicine and Rheumatology, Pathology and Gastro-enterology, Tel-Aviv Government Municipal Hospitals and Tel-Aviv University Sackler School of Medicine

A 45-year-old female with classical rheumatoid arthritis was started on Myocrisin injections. After receiving 130 mg Myocrisin (equivalent to 65 mg gold) she developed severe diarrhoea which was unresponsive to steroids, British Anti-Lewisite (B.A.L.) and all other conservative treatments. A rectal biopsy showed severe inflammation. Malabsorption of fat and carbohydrate was demonstrated. During hospitalization diarrhoea continued, she developed hypoproteinaemia and died. Post-mortem examination revealed severe lung infection with abscess formation and severe changes in the colon. Gold concentrations in different organs are reported.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.